Latest filing published 02 Oct 2020 for Herantis pharma, €11k.
Filing timeline
BuySaleInsider track record
Ingrid Atteryd Heiman: trading record in brief
Ingrid Atteryd Heiman appears in our data through filings on Herantis pharma shares, published by Finansinspektionen. In total, 3 filings cover trades dated from 18 September 2020 to 2 October 2020.
Sales make up the whole of the open-market record (3 sales, €73k).
On 2 October 2020 came the latest disclosure, an open-market sale for €11k in Herantis pharma. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The regulation allows three business days to notify a trade (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ingrid Atteryd Heiman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,528 shares@ SEK 72.523814.6% of flowAktieISIN FI4000087861FI:csv-dabda56d5b42b61da5f2
- 3,888 shares@ SEK 71.978836.8% of flowAktieISIN FI4000087861FI:csv-bfc916c3348c8c45d4db
- 4,584 shares@ SEK 80.071548.6% of flowAktieISIN FI4000087861FI:csv-1221ecf64a3677ebacfd
3 of 3 declarations